Verification evidence is still being completed.
PDF / print export
Genovis
Kävlinge, Sweden
- Verified lead
- Fredrik Olsson
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Biologics Sample Preparation, Enzyme Tools, and Analytical Workflows
- Review cycle
- May 2026
- Full address
- Karl Johans väg 104, SE-244 21 Kävlinge, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Genovis management page confirming Fredrik Olsson as CEO.
- Editorial note
- Genovis adds a source-backed Swedish tools node relevant to biologics preparation, characterization, and downstream analytical quality.
Biologics Sample Preparation, Enzyme Tools, and Analytical Workflows
Biologics analytical workflow platform, Quality-managed life science supply
Genovis adds a source-backed Swedish tools node relevant to biologics preparation, characterization, and downstream analytical quality.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Genovis adds a source-backed Swedish tools node relevant to biologics preparation, characterization, and downstream analytical quality.
- Lead
- Fredrik Olsson (verified ↗)
- Address
- Karl Johans väg 104, SE-244 21 Kävlinge, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global research and QC supply
- Capabilities
- Protein Preparation Enzymes · Biologics Characterization · Analytical Workflow Integration
- Founded
- 1999
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Fredrik Olsson
Chief Executive Officer
Full addressKarl Johans väg 104, SE-244 21 Kävlinge, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Global research and QC supply
Kävlinge, Sweden. Biologics Sample Preparation, Enzyme Tools, and Analytical Workflows. Review completed on 14 Mar 2026.
Swedish and EU life-science supply oversight
Biologics analytical workflow platform, Quality-managed life science supply
Biologics Sample Preparation, Enzyme Tools, and Analytical Workflows
Genovis adds a source-backed Swedish tools node relevant to biologics preparation, characterization, and downstream analytical quality.
Related companies
Editorial note
Genovis adds a source-backed Swedish tools node relevant to biologics preparation, characterization, and downstream analytical quality.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Protein Preparation Enzymes
Biologics Characterization
Analytical Workflow Integration
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Enzyme production systems
Analytical workflow support labs
Life-science distribution systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Trust review remains in progress.
FAQ
Frequently asked questions
- Where is Genovis located?
- Genovis operates from Karl Johans väg 104, SE-244 21 Kävlinge, Sweden, Kävlinge, Sweden.
- Who runs Genovis?
- Genovis is led by Fredrik Olsson, Chief Executive Officer. Verified 14 Mar 2026.
- What does Genovis do?
- Genovis adds a source-backed Swedish tools node relevant to biologics preparation, characterization, and downstream analytical quality. Core capabilities: Protein Preparation Enzymes, Biologics Characterization, Analytical Workflow Integration.
Editorial context
Related technical briefs
Briefs that name Kävlinge as a covered market or city.